How does cowberry work as a urinary antiseptic?

Cowberry works primarily through its arbutin content, a compound that hydrolyzes into hydroquinone in the urinary tract. This process creates an antiseptic environment that inhibits bacterial growth, making it effective against pathogens responsible for urinary tract infections. Additionally, the herb contains anthocyanins and flavonoids like quercetin, which reduce inflammation and provide antioxidant support. Evidence Level: C.

Is cowberry safe to take during pregnancy?

Cowberry is generally considered safe when consumed as a food in moderate dietary amounts during pregnancy. However, medicinal doses or concentrated extracts are contraindicated due to the arbutin content, which can convert to hydroquinone and potentially stimulate uterine contractions or stress kidney function. Pregnant women should avoid high-dose supplements and consult a healthcare provider before use. Evidence Level: Traditional.

What is the recommended dosage for cowberry?

Traditional usage suggests a daily intake of 50 to 100 grams of fresh berries or approximately 200ml of unsweetened juice. For standardized extracts, dosage should follow manufacturer guidelines based on arbutin concentration. Because cowberry acts as a diuretic and urinary antiseptic, it is essential to maintain adequate fluid intake while using this herb. Evidence Level: C.

Does cowberry interact with any medications?

While specific clinical trials are limited (Evidence Level C), cowberry may theoretically interact with medications that acidify urine or affect kidney function. Because arbutin metabolizes into hydroquinone, there is a potential risk of interaction with drugs metabolized by the liver. Patients taking diuretics or lithium should exercise caution, as cowberry may alter drug clearance rates and urinary excretion.

What are the main benefits of cowberry?

Cowberry is primarily used in Scandinavian and Russian folk medicine as a urinary antiseptic for treating urinary tract infections and supporting kidney health. Historically, it was also used to prevent and treat scurvy due to its high vitamin C content. Modern herbalists utilize the leaves and berries for immune support and to soothe mouth and throat infections. Evidence Level: C.

Cowberry (Vaccinium vitis-idaea)

Fiche d'information compilée à partir de PubMed

Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.

Compilé à partir de 28 articles PubMed · modèle : gemma4:31b

Résumé

Cowberry (Vaccinium vitis-idaea), also known as lingonberry, is a berry from the Ericaceae family recognized for its high antioxidant content and various health-promoting properties [PMID:34066191].

Contexte

Vaccinium vitis-idaea is a low-bush wild plant found in the northern hemisphere, including Scandinavia, northern Eurasia, Alaska, and Canada [PMID:34835994, PMID:38142435]. It produces tart, nutty red berries and is considered a 'superfruit' due to its high antioxidant levels [PMID:38142435, PMID:34066191].

Usages traditionnels

Traditionally used in Asian and European countries for urinary tract infections, gastrointestinal distress, neurodegenerative diseases, and related inflammatory disorders [PMID:35306039]. In Finland, it is used to treat oral yeast infections [PMID:34835994], and it has been used by the Cree of Eeyou Istchee in northern Quebec to treat symptoms of diabetes [PMID:25013446].

Composés actifs

The plant contains bioactive phenolics, including proanthocyanidins (comprising 63-71% of total phenolic content), anthocyanins (such as cyanidin-3-glucoside), hydroxycinnamic acids, hydroxybenzoic acids, and flavonols [PMID:21370878, PMID:26024018]. Specific compounds identified in leaves include arbutin, apigenin, sorbitol, and hesperidin [PMID:38231701, PMID:30818858, PMID:25408277].

Mécanisme d'action

Lingonberry extracts may enhance glucose uptake via stimulation of the AMP-activated protein kinase (AMPK) pathway [PMID:25013446]. In hepatic lipid metabolism, it has been shown to inhibit Notch1 signaling [PMID:35326122]. Additionally, its phenolic compounds can promote macrophage polarization toward the anti-inflammatory M2 phenotype [PMID:36551801].

Preuves cliniques

Preuve DOral Candidiasis (Thrush)

Routine therapy using acidic liquids such as lingonberry juice was used in newborns to treat oral candidiasis [PMID:31687193]

Preuve DType 2 Diabetes/Obesity

In mouse models, V. vitis-idaea extract significantly decreased glycemia and tended to decrease insulin levels by increasing GLUT4 content and activating the AMPK pathway [PMID:25013446]. Skin extract from press cake partly prevented weight gain and hyperglycemia in high-fat diet-induced obese mice [PMID:38999854]

Preuve DNon-alcoholic Fatty Liver Disease (NAFLD)

Supplementation inhibited hepatic Notch1 signaling and improved the lipid profile in mouse models [PMID:35326122]

Preuve DIschemia-Reperfusion (IR) Injury

Methanolic extracts and anthocyanin-rich fractions inhibited apoptosis in H9c2 cells by inhibiting markers such as caspase-3 activation and MAP kinase [PMID:26024018]

Preuve DAtopic Dermatitis

A liposomal gel using V. vitis-idaea polyphenol demonstrated anti-inflammatory, antibacterial, and antioxidant effects in ex vivo and in vivo studies [PMID:39957257]

Sécurité et effets indésirables

No specific safety data for V. vitis-idaea provided; however, related Vaccinium species (cranberries) are generally well tolerated, though large doses may cause stomach discomfort and diarrhea [PMID:30000897].

Interactions médicamenteuses

No specific data for V. vitis-idaea; however, some cases of elevated INR have been reported in patients taking cranberry (a related Vaccinium species) and warfarin [PMID:30000897].

Synthèse des preuves

The current evidence is primarily based on in vitro studies, animal models (mice), and reviews. There is a lack of high-level human clinical trial data (RCTs or meta-analyses) to confirm therapeutic efficacy in humans.

Sources PubMed

1.PMID: 30000897 (2006) — Revealing Lingonberry's Neuroprotective Potential in Alzheimer's Disease Through Network Pharmacology and Molecular Docking. · International journal of molecular sciences
2.PMID: 34066191 (2021) — Lingonberry (Vaccinium vitis-idaea L.) Fruit as a Source of Bioactive Compounds with Health-Promoting Effects-A Review. · International journal of molecular sciences
3.PMID: 39338523 (2024) — Lingonberry (Vaccinium vitis-idaea L.) Fruit Phenolic Bioactivities-A Review of In Vitro and In Vivo Human Studies. · Microorganisms
4.PMID: 38142435 (2024) — Unveiling the evolutionary history of lingonberry (Vaccinium vitis-idaea L.) through genome sequencing and assembly of European and North American subspecies. · G3 (Bethesda, Md.)
5.PMID: 36140930

Cowberry

Sources et citations